Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alembic Pharmaceuticals Ltd.
NSE: APLLTD
|
BSE: 533573
|
ISIN: INE901L01018
|
Industry: Pharmaceuticals
USFDA Approval
Insider Trades
|
Mid-range Performer
937.7500
-9.55
(
-1.01
%)
NSE
Sep 09, 2025
15:31 PM
28.08% Fall from 52W High
Volume:
73,236
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alembic Pharmaceuticals Ltd.
05 Aug 2022
USFDA Approval
Insider Trades
937.75
-1.01%
Successful compliance at its Injectables site key to an earnings revival
Sell:
Alembic Pharmaceuticals Ltd.
by
Motilal Oswal
Target: 590
Recommendation
Target
Motilal Oswal
Alembic Pharmaceutic.. has an
average target
of 1001.00 from 4 brokers.
More from Alembic Pharmaceuticals Ltd.
Recommended
Five stocks to buy from analysts this week - September 9, 2025
The Baseline |
09 Sep 2025, 05:38PM
Market closes higher, Waaree Renewable bags a Rs 1,252 crore solar project
Trendlyne Marketwatch |
09 Sep 2025, 04:00PM
Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals
|
22 Jul 2020